Literature DB >> 28984304

Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.

Masashi Miyaoka1, Yara Y Kikuti1, Joaquim Carreras1, Haruka Ikoma1, Shinichiro Hiraiwa1, Akifumi Ichiki2, Minoru Kojima2, Kiyoshi Ando2, Tomoyuki Yokose3, Rika Sakai4, Masahiro Hoshikawa5, Naoto Tomita6, Ikuo Miura6, Katsuyoshi Takata7, Tadashi Yoshino7, Jun Takizawa8, Silvia Bea9, Elias Campo9, Naoya Nakamura1.   

Abstract

Most high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements are aggressive B-cell lymphomas. Occasional double-hit follicular lymphomas have been described but the clinicopathological features of these tumors are not well known. To clarify the characteristics of double-hit follicular lymphomas, we analyzed 10 cases of double-hit follicular lymphomas and 15 cases of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements for clinicopathological and genome-wide copy-number alterations and copy-neutral loss-of-heterozygosity profiles. For double-hit follicular lymphomas, the median age was 67.5 years (range: 48-82 years). The female/male ratio was 2.3. Eight patients presented with advanced clinical stage. The median follow-up time was 20 months (range: 1-132 months). At the end of the follow-up, 8 patients were alive, 2 patients were dead including 1 patient with diffuse large B-cell lymphoma transformation. Rearrangements of MYC/BCL2, MYC/BCL6, and MYC/BCL2/BCL6 were seen in 8, 1, and 1 cases, respectively. The partner of MYC was IGH in 6 cases. There were no cases of histological grade 1, 4 cases of grade 2, 5 cases of grade 3a, and 1 case of grade 3b. Two cases of grade 3a exhibited immunoblast-like morphology. Immunohistochemistry demonstrated 9 cases with ≥50% MYC-positive cells. There was significant difference in MYC intensity (P=0.00004) and MIB-1 positivity (P=0.001) between double-hit follicular lymphomas and high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements. The genome profile of double-hit follicular lymphomas was comparable with conventional follicular lymphomas (GSE67385, n=198) with characteristic gains of 2p25.3-p11.1, 7p22.3-q36.3, 12q11-q24.33, and loss of 18q21.32-q23 (P<0.05). In comparison with high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements, double-hit follicular lymphomas had fewer copy-number alterations and minimal common region of gain at 2p16.1 (70%), locus also significant against conventional follicular lymphomas (P=0.0001). In summary, double-hit follicular lymphomas tended to be high-grade histology, high MYC protein expression, high MYC/IGH fusion, and minimal common region of gain at 2p16.1. Double-hit follicular lymphomas seemed to be a different disease from high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements and have an indolent clinical behavior similar to follicular lymphomas without MYC rearrangement.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28984304     DOI: 10.1038/modpathol.2017.134

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  27 in total

Review 1.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Authors:  B D Cheson; S J Horning; B Coiffier; M A Shipp; R I Fisher; J M Connors; T A Lister; J Vose; A Grillo-López; A Hagenbeek; F Cabanillas; D Klippensten; W Hiddemann; R Castellino; N L Harris; J O Armitage; W Carter; R Hoppe; G P Canellos
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

2.  B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Authors:  Matija Snuderl; Olga K Kolman; Yi-Bin Chen; Jessie J Hsu; Adam M Ackerman; Paola Dal Cin; Judith A Ferry; Nancy Lee Harris; Robert P Hasserjian; Lawrence R Zukerberg; Jeremy S Abramson; Ephraim P Hochberg; Hang Lee; Alfred I Lee; Christiana E Toomey; Aliyah R Sohani
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

3.  Molecular pathogenesis of follicular lymphoma.

Authors:  German Ott; Andreas Rosenwald
Journal:  Haematologica       Date:  2008-12       Impact factor: 9.941

4.  Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.

Authors:  Sietse M Aukema; Markus Kreuz; Christian W Kohler; Maciej Rosolowski; Dirk Hasenclever; Michael Hummel; Ralf Küppers; Dido Lenze; German Ott; Christiane Pott; Julia Richter; Andreas Rosenwald; Monika Szczepanowski; Carsten Schwaenen; Harald Stein; Heiko Trautmann; Swen Wessendorf; Lorenz Trümper; Markus Loeffler; Rainer Spang; Philip M Kluin; Wolfram Klapper; Reiner Siebert
Journal:  Haematologica       Date:  2013-10-31       Impact factor: 9.941

5.  Expression profiles of MYC protein and MYC gene rearrangement in lymphomas.

Authors:  Karen M Chisholm; Charles D Bangs; Carlos E Bacchi; Hernan Molina-Kirsch; Athena Cherry; Yasodha Natkunam
Journal:  Am J Surg Pathol       Date:  2015-03       Impact factor: 6.394

Review 6.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

Review 7.  Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.

Authors:  Yuan Miao; Shimin Hu; Xinyan Lu; Shaoying Li; Wei Wang; L Jeffrey Medeiros; Pei Lin
Journal:  Hum Pathol       Date:  2016-08-18       Impact factor: 3.466

8.  Follicular lymphoma international prognostic index.

Authors:  Philippe Solal-Céligny; Pascal Roy; Philippe Colombat; Josephine White; Jim O Armitage; Reyes Arranz-Saez; Wing Y Au; Monica Bellei; Pauline Brice; Dolores Caballero; Bertrand Coiffier; Eulogio Conde-Garcia; Chantal Doyen; Massimo Federico; Richard I Fisher; Javier F Garcia-Conde; Cesare Guglielmi; Anton Hagenbeek; Corinne Haïoun; Michael LeBlanc; Andrew T Lister; Armando Lopez-Guillermo; Peter McLaughlin; Noël Milpied; Pierre Morel; Nicolas Mounier; Stephen J Proctor; Ama Rohatiner; Paul Smith; Pierre Soubeyran; Hervé Tilly; Umberto Vitolo; Pier-Luigi Zinzani; Emanuele Zucca; Emili Montserrat
Journal:  Blood       Date:  2004-05-04       Impact factor: 22.113

9.  Immunoblastic follicular lymphoma: a very unusual transformation of low-grade follicular lymphoma.

Authors:  Shereen Gheith; Dennis Cornfield; Weiyi Chen; Pal Singh-Kahlon; Basil Ahmed
Journal:  Hum Pathol       Date:  2014-08-13       Impact factor: 3.466

Review 10.  Novel Drugs in Follicular Lymphoma.

Authors:  Antonella Anastasia; Giuseppe Rossi
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-11-01       Impact factor: 2.576

View more
  6 in total

Review 1.  Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma.

Authors:  Rebecca L King; Eric D Hsi; Wing C Chan; Miguel A Piris; James R Cook; David W Scott; Steven H Swerdlow
Journal:  Virchows Arch       Date:  2022-09-03       Impact factor: 4.535

2.  Unusual presentation of extra-nodal double-hit follicular lymphoma: a case report.

Authors:  Stefano Lazzi; Massimo Granai; Marco Capanni; Falko Fend
Journal:  BMC Gastroenterol       Date:  2022-05-20       Impact factor: 2.847

Review 3.  The broad landscape of follicular lymphoma: Part I.

Authors:  Stefano Fratoni; Magda Zanelli; Maurizio Zizzo; Francesca Sanguedolce; Valentina Aimola; Giulia Cerrone; Linda Ricci; Alessandra Filosa; Giovanni Martino; Stefano Ascani
Journal:  Pathologica       Date:  2020-01-22

4.  Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas.

Authors:  Ivonne Vazquez; Natalia Papaleo; Eugenia Garcia; Marta Salido; Antonio Salar; Silvia Hernandez; Xavier Calvo; Luis Colomo
Journal:  Cancers (Basel)       Date:  2020-04-05       Impact factor: 6.639

Review 5.  The broad landscape of follicular lymphoma: Part II.

Authors:  Stefano Fratoni; Magda Zanelli; Maurizio Zizzo; Francesca Sanguedolce; Valentina Aimola; Giulia Cerrone; Linda Ricci; Alessandra Filosa; Giovanni Martino; Antonella Maria Fara; Valerio Annessi; Alessandra Soriano; Stefano Ascani
Journal:  Pathologica       Date:  2020-03-12

Review 6.  Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies.

Authors:  Ibolya Czegle; Austin L Gray; Minjing Wang; Yan Liu; Jun Wang; Edina A Wappler-Guzzetta
Journal:  Life (Basel)       Date:  2021-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.